Clinical Trial Update: Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated gemcitabine as maintenance therapy for diffuse pleural mesothelioma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Pleural Mesothelioma

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Diffuse Pleural Mesothelioma (DPM) | Phase 2 | Status: COMPLETED